Pulmonary embolism (PE) is a life-threatening condition in which a blood clot travels to the lungs, lodging in the pulmonary arteries and blocking blood flow. It is a serious medical emergency that requires prompt diagnosis and treatment. The risk factors for PE include age, gender, certain medical conditions, lifestyle choices, and family history. In this comprehensive guide, we will explore the risk factors associated with PE and discuss ways to reduce your risk.
Age is one of the most significant risk factors for developing PE. The risk of PE increases with age, with the highest risk group being those over the age of 75. This is likely due to the increased likelihood of developing other medical conditions, such as deep vein thrombosis, which can lead to the formation of a blood clot that can then travel to the lungs.
Women are at a higher risk of developing PE than men. This is likely due to the fact that women tend to have higher levels of hormones, such as estrogen, which can increase the risk of blood clotting. Additionally, women are more likely to take certain medications, such as birth control pills, which can also increase the risk of developing PE.
Certain medical conditions can increase the risk of developing PE. These include cancer, heart disease, stroke, obesity, and inflammatory bowel disease. Additionally, certain medications, such as those used to treat cancer or autoimmune diseases, can also increase the risk of PE.
Certain lifestyle choices can also increase the risk of developing PE. These include smoking, being sedentary, and being immobile for extended periods of time (such as during a long plane flight). Additionally, those who are pregnant or have recently given birth are at an increased risk of developing PE.
Having a family history of PE can also increase the risk of developing the condition. This is likely due to the fact that certain genetic factors can increase the risk of clotting. Additionally, those with a family history of certain medical conditions, such as cancer or heart disease, may also be at an increased risk of developing PE.
Although some risk factors for PE cannot be changed (such as age and family history), there are steps you can take to reduce your risk. These include: • Maintaining a healthy weight. • Exercising regularly. • Not smoking. • Taking medications as prescribed. • Avoiding long periods of immobility, such as during a long plane flight. • Wearing compression stockings if you are at an increased risk of blood clots.
Pulmonary embolism is a serious medical emergency that requires prompt diagnosis and treatment. The risk factors for PE include age, gender, certain medical conditions, lifestyle choices, and family history. By understanding the risk factors associated with PE and taking steps to reduce your risk, you can help to prevent this potentially life-threatening condition.
1.
What is Mohs micrographic surgery? 8 FAQs about Mohs
2.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
3.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
1.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation